Search
for
Sort by
Research 241–270 of 1000+
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- 43647 Treatment of Refractory Folliculitis Decalvans with the Topical JAK Inhibitor Tofacitinib
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- New drugs under investigation for the treatment of alopecias
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Evidence for the off-label use of tofacitinib in alopecia areata
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Topical tofacitinib in treatment of alopecia areata
- Hair Growth After Gefitinib Treatment
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Hair Re-Pigmentation After Nilotinib
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- JAK inhibitors in dermatology: The promise of a new drug class
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Treatment of severe alopecia areata with baricitinib
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Under Development JAK Inhibitors for Dermatologic Diseases
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review